DaVita participates in UBS, Wolfe Research healthcare conferences

DVA•2026-11-03

DaVita will participate in fireside chats at the UBS Global Healthcare Conference on Nov. 9, 2026, and the Wolfe Research Healthcare Conference on Nov. 10.

1. Conference appearances

Chief Financial Officer Joel Ackerman and Group Vice President of Investor Relations Nic Eliason will represent DaVita at both conferences. The UBS chat is scheduled for 1:15 p.m. EST on Nov. 9, and the Wolfe Research chat for 8:40 a.m. EST on Nov. 10.

DaVita participates in UBS, Wolfe Research healthcare conferences

1. Conference appearances

Related News

Zentalis Pharmaceuticals to participate in Guggenheim and Stifel healthcare conferences

First American Financial declares quarterly cash dividend of 61 cents per share

Mosaic announces availability of third-quarter 2026 earnings release

SL Science Holding names Chin-Sheng Hung director and chief medical officer

MacroGenics grants director Emil Kuriakose 44,000 stock options, 7,500 restricted stock units